The DOI matches its Crossref record; 70 of the 70 references it cites were found in a registry or an index.
The Most Common Functional Groups in Bioactive Molecules and How Their Popularity Has Evolved over Time
Abstract
The concept of functional groups (FGs), sets of connected atoms that can determine the intrinsic reactivity of the parent molecule and in part are responsible for the overall properties of the molecule, form a foundation within modern medicinal chemistry. In this Article, we analyze the occurrence of various FGs in molecules described in the medicinal chemistry literature over the last 40 years and show how their development and utilization over time has varied. The popularity of various FGs has not evolved randomly, but instead, clear patterns of use are evident. Various factors influencing these patterns, including the introduction of new synthetic methods, novel techniques, and strategies applied in drug discovery and the better knowledge of molecular properties affecting the success of candidate development, are discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00129-0 · Cited by 18,139
Fluorine in Pharmaceuticals: Looking Beyond Intuition
Müller, K., Faeh, C., & Diederich, F. (2007) · Science · doi:10.1126/science.1131943 · Cited by 6,596
Baell, J. B., & Holloway, G. A. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm901137j · Cited by 3,944
ZINC 15 – Ligand Discovery for Everyone
Sterling, T., & Irwin, J. J. (2015) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.5b00559 · Cited by 3,224
The Medicinal Chemist’s Toolbox: An Analysis of Reactions Used in the Pursuit of Drug Candidates
Roughley, S. D., & Jordan, A. M. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm200187y · Cited by 2,725
Fluorine and Fluorinated Motifs in the Design and Application of Bioisosteres for Drug Design
Meanwell, N. A. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b01788 · Cited by 2,655
ChEMBL: towards direct deposition of bioassay data
Mendez, D., Gaulton, A., Bento, A. P., Chambers, J., De Veij, M., Félix, E., Magariños, M. P., Mosquera, J. F., Mutowo, P., Nowotka, M., et al. (2019) · Nucleic Acids Research · doi:10.1093/nar/gky1075 · Cited by 2,372
Rethinking amide bond synthesis
Pattabiraman, V. R., & Bode, J. W. (2011) · Nature · doi:10.1038/nature10702 · Cited by 2,164
Brown, D. G., & Boström, J. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01409 · Cited by 1,964
Analysis of the reactions used for the preparation of drug candidate molecules
Carey, J. S., Laffan, D., Thomson, C., & Williams, M. T. (2006) · Organic & Biomolecular Chemistry · doi:10.1039/b602413k · Cited by 1,915
The resurgence of covalent drugs
Singh, J., Petter, R. C., Baillie, T. A., & Whitty, A. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3410 · Cited by 1,873
Nitrile-Containing Pharmaceuticals: Efficacious Roles of the Nitrile Pharmacophore
Fleming, F. F., Yao, L., Ravikumar, P. C., Funk, L., & Shook, B. C. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm100762r · Cited by 1,754
Yang, X., Wu, T., Phipps, R. J., & Toste, F. D. (2015) · Chemical Reviews · doi:10.1021/cr500277b · Cited by 1,383
Principles and Applications of Halogen Bonding in Medicinal Chemistry and Chemical Biology
Wilcken, R., Zimmermann, M. O., Lange, A., Joerger, A. C., & Boeckler, F. M. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm3012068 · Cited by 1,331
The role of fluorine in medicinal chemistry: Review Article
Shah, P., & Westwell, A. D. (2007) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756360701425014 · Cited by 799
The expanding role of prodrugs in contemporary drug design and development
Rautio, J., Meanwell, N. A., Di, L., & Hageman, M. J. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.46 · Cited by 767
Discovery of a Covalent Inhibitor of KRAS G12C (AMG 510) for the Treatment of Solid Tumors
Lanman, B. A., Allen, J. R., Allen, J. G., Amegadzie, A. K., Ashton, K. S., Booker, S. K., Chen, J. J., Chen, N., Frohn, M. J., Goodman, G., et al. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b01180 · Cited by 765
The 1,2,3-triazole ring as a bioisostere in medicinal chemistry
Bonandi, E., Christodoulou, M. S., Fumagalli, G., Perdicchia, D., Rastelli, G., & Passarella, D. (2017) · Drug Discovery Today · doi:10.1016/j.drudis.2017.05.014 · Cited by 743
Organic Carbamates in Drug Design and Medicinal Chemistry
Ghosh, A. K., & Brindisi, M. (2015) · Journal of Medicinal Chemistry · doi:10.1021/jm501371s · Cited by 739
Halogen atoms in the modern medicinal chemistry: hints for the drug design
Hernandes, M., Cavalcanti, S. M., Moreira, D. R., de Azevedo Junior, W., & Leite, A. C. (2010) · Current Drug Targets · doi:10.2174/138945010790711996 · Cited by 723
Gehringer, M., & Laufer, S. A. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b01153 · Cited by 714
Sulfoximines: A Neglected Opportunity in Medicinal Chemistry
Lücking, U. (2013) · Angewandte Chemie International Edition · doi:10.1002/anie.201302209 · Cited by 672
Expanding the medicinal chemistry synthetic toolbox
Boström, J., Brown, D. G., Young, R. J., & Keserü, G. M. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.116 · Cited by 665
Fell, J. B., Fischer, J. P., Baer, B. R., Blake, J. F., Bouhana, K., Briere, D. M., Brown, K. D., Burgess, L. E., Burns, A. C., Burkard, M. R., et al. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b02052 · Cited by 653
Zhao, C., Rakesh, K. P., Ravidar, L., Fang, W.-Y., & Qin, H.-L. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.11.017 · Cited by 651
Bauer, R. A. (2015) · Drug Discovery Today · doi:10.1016/j.drudis.2015.05.005 · Cited by 534
Carboxylic Acid (Bio)Isosteres in Drug Design
Ballatore, C., Huryn, D. M., & Smith, A. B. (2013) · ChemMedChem · doi:10.1002/cmdc.201200585 · Cited by 523
Frings, M., Bolm, C., Blum, A., & Gnamm, C. (2017) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.09.091 · Cited by 501
Managing the challenge of chemically reactive metabolites in drug development
Park, B. K., Boobis, A., Clarke, S., Goldring, C. E. P., Jones, D., Kenna, J. G., Lambert, C., Laverty, H. G., Naisbitt, D. J., Nelson, S., et al. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3408 · Cited by 462
Shultz, M. D. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b00686 · Cited by 434
Schneider, N., Lowe, D. M., Sayle, R. A., Tarselli, M. A., & Landrum, G. A. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b00153 · Cited by 427
What Do Medicinal Chemists Actually Make? A 50-Year Retrospective
Walters, W. P., Green, J., Weiss, J. R., & Murcko, M. A. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm200504p · Cited by 387
Benigni, R., & Bossa, C. (2011) · Chemical Reviews · doi:10.1021/cr100222q · Cited by 377
Lücking, U. (2019) · Organic Chemistry Frontiers · doi:10.1039/c8qo01233d · Cited by 364
A Systematic Cheminformatics Analysis of Functional Groups Occurring in Natural Products
Ertl, P., & Schuhmann, T. (2019) · Journal of Natural Products · doi:10.1021/acs.jnatprod.8b01022 · Cited by 358
Self-citationCamenisch, G., Alsenz, J., van de Waterbeemd, H., & Folkers, G. (1998) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(97)10019-7 · Cited by 347
Rules for Identifying Potentially Reactive or Promiscuous Compounds
Bruns, R. F., & Watson, I. A. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm301008n · Cited by 338
Foote, K. M., Nissink, J. W. M., McGuire, T., Turner, P., Guichard, S., Yates, J. W. T., Lau, A., Blades, K., Heathcote, D., Odedra, R., et al. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b01187 · Cited by 332
Cooper, T. W. J., Campbell, I. B., & Macdonald, S. J. F. (2010) · Angewandte Chemie International Edition · doi:10.1002/anie.201002238 · Cited by 299
Lysosomal Sequestration of Amine-Containing Drugs: Analysis and Therapeutic Implications
Kaufmann, A. M., & Krise, J. P. (2007) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20792 · Cited by 284
Michel, J., Tirado-Rives, J., & Jorgensen, W. L. (2009) · Journal of the American Chemical Society · doi:10.1021/ja906058w · Cited by 256
Ertl, P., Jelfs, S., Mühlbacher, J., Schuffenhauer, A., & Selzer, P. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm060217p · Cited by 254
Self-citationHuchet, Q. A., Kuhn, B., Wagner, B., Kratochwil, N. A., Fischer, H., Kansy, M., Zimmerli, D., Carreira, E. M., & Müller, K. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01455 · Cited by 239
Lysine‐Targeting Covalent Inhibitors
Pettinger, J., Jones, K., & Cheeseman, M. D. (2017) · Angewandte Chemie International Edition · doi:10.1002/anie.201707630 · Cited by 236
SureChEMBL: a large-scale, chemically annotated patent document database
Papadatos, G., Davies, M., Dedman, N., Chambers, J., Gaulton, A., Siddle, J., Koks, R., Irvine, S. A., Pettersson, J., Goncharoff, N., et al. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkv1253 · Cited by 229
Lücking, U., Jautelat, R., Krüger, M., Brumby, T., Lienau, P., Schäfer, M., Briem, H., Schulze, J., Hillisch, A., Reichel, A., et al. (2013) · ChemMedChem · doi:10.1002/cmdc.201300096 · Cited by 182
Angst, D., Gessier, F., Janser, P., Vulpetti, A., Wälchli, R., Beerli, C., Littlewood-Evans, A., Dawson, J., Nuesslein-Hildesheim, B., Wieczorek, G., et al. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b01916 · Cited by 172
An algorithm to identify functional groups in organic molecules
Ertl, P. (2017) · Journal of Cheminformatics · doi:10.1186/s13321-017-0225-z · Cited by 159
Self-citationFluorine in Drug Design: A Case Study with Fluoroanisoles
Li, X., Blakemore, D. C., Narayanan, A., Unwalla, R. J., Lovering, F., Denny, R. A., Zhou, H., & Bunnage, M. E. (2015) · ChemMedChem · doi:10.1002/cmdc.201402555 · Cited by 155
A Survey of the Role of Nitrile Groups in Protein–Ligand Interactions
Wang, Y. E., Du, Y., & Huang, N. (2018) · Future Medicinal Chemistry · doi:10.4155/fmc-2018-0252 · Cited by 150
Lysine-Targeted Inhibitors and Chemoproteomic Probes
Cuesta, A., & Taunton, J. (2019) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-061516-044805 · Cited by 149
Selective and reversible modification of kinase cysteines with chlorofluoroacetamides
Shindo, N., Fuchida, H., Sato, M., Watari, K., Shibata, T., Kuwata, K., Miura, C., Okamoto, K., Hatsuyama, Y., Tokunaga, K., et al. (2019) · Nature Chemical Biology · doi:10.1038/s41589-018-0204-3 · Cited by 146
Polyfluorinated Ethanes as Versatile Fluorinated C2-Building Blocks for Organic Synthesis
Nenajdenko, V. G., Muzalevskiy, V. M., & Shastin, A. V. (2015) · Chemical Reviews · doi:10.1021/cr500465n · Cited by 140
On the polarity of partially fluorinated methyl groups
Huchet, Q. A., Kuhn, B., Wagner, B., Fischer, H., Kansy, M., Zimmerli, D., Carreira, E. M., & Müller, K. (2013) · Journal of Fluorine Chemistry · doi:10.1016/j.jfluchem.2013.02.023 · Cited by 119
Recent progress on third generation covalent EGFR inhibitors
Cheng, H., Nair, S. K., & Murray, B. W. (2016) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2016.02.067 · Cited by 116
New Electrophiles and Strategies for Mechanism-Based and Targeted Covalent Inhibitor Design
Ray, S., & Murkin, A. S. (2019) · Biochemistry · doi:10.1021/acs.biochem.9b00293 · Cited by 108
Insight into the structural determinants for selective inhibition of matrix metalloproteinases
Pirard, B. (2007) · Drug Discovery Today · doi:10.1016/j.drudis.2007.06.003 · Cited by 100
Applications of amide isosteres in medicinal chemistry
Sun, S., Jia, Q., & Zhang, Z. (2019) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2019.07.033 · Cited by 98
Kutchukian, P. S., Vasilyeva, N. Y., Xu, J. C., Lindvall, M., Dillon, M. P., Glick, M., Coley, J. D., & Brooijmans, N. (2012) · PLoS ONE · doi:10.1371/journal.pone.0048476 · Cited by 90
Qualitative structure-metabolism relationships in the hydrolysis of carbamates
Vacondio, F., Claudia, S., Mor, M., & Testa, B. (2010) · Drug Metabolism Reviews · doi:10.3109/03602531003745960 · Cited by 79
Discovery of Tankyrase Inhibiting Flavones with Increased Potency and Isoenzyme Selectivity
Narwal, M., Koivunen, J. T., Haikarainen, T., Obaji, E., Legala, O. E., Venkannagari, H., Joensuu, P., Pihlajaniemi, T. A., & Lehtiö, L. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm401463y · Cited by 65
Drew, K. L. M., & Reynisson, J. (2012) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2012.08.017 · Cited by 50
Development of Specific “Drug‐Like Property” Rules for Carboxylate‐Containing Oral Drug Candidates
Böcker, A., Bonneau, P. R., Hucke, O., Jakalian, A., & Edwards, P. J. (2010) · ChemMedChem · doi:10.1002/cmdc.201000355 · Cited by 49
Sun, H., E. Keefer, C., & O. Scott, D. (2011) · Drug Metabolism Letters · doi:10.2174/187231211798472575 · Cited by 45
Recent progress in prodrug design strategies based on generally applicable modifications
Hamada, Y. (2017) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2017.02.075 · Cited by 43
Bashore, C., Jaishankar, P., Skelton, N. J., Fuhrmann, J., Hearn, B. R., Liu, P. S., Renslo, A. R., & Dueber, E. C. (2020) · ACS Chemical Biology · doi:10.1021/acschembio.0c00031 · Cited by 34
Dawadi, S., Viswanathan, K., Boshoff, H. I., Barry, C. E., & Aldrich, C. C. (2015) · The Journal of Organic Chemistry · doi:10.1021/acs.joc.5b00550 · Cited by 32
Pyrazole NNRTIs 3: Optimisation of physicochemical properties
Mowbray, C. E., Corbau, R., Hawes, M., Jones, L. H., Mills, J. E. J., Perros, M., Selby, M. D., Stupple, P. A., Webster, R., & Wood, A. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.08.043 · Cited by 31
Briguglio, I., Laurini, E., Pirisi, M. A., Piras, S., Corona, P., Fermeglia, M., Pricl, S., & Carta, A. (2017) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2017.09.065 · Cited by 23
Fritsch, S., Neumann, S., Schaub, J., Steinbeck, C., & Zielesny, A. (2019) · Journal of Cheminformatics · doi:10.1186/s13321-019-0361-8 · Cited by 12
Cited by
Green metrics in mechanochemistry
Fantozzi, N., Volle, J.-N., Porcheddu, A., Virieux, D., García, F., & Colacino, E. (2023) · Chemical Society Reviews · doi:10.1039/d2cs00997h · Cited by 336
“Magic Chloro”: Profound Effects of the Chlorine Atom in Drug Discovery
Chiodi, D., & Ishihara, Y. (2023) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c02015 · Cited by 263
Masui, H., & Fuse, S. (2022) · Organic Process Research & Development · doi:10.1021/acs.oprd.2c00074 · Cited by 38
Metadata
- Authors
- Ertl, P., Altmann, E., & McKenna, J. M.
- Venue
- Journal of Medicinal Chemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 2020-07-14
- Volume
- 63
- Issue
- 15
- Pages
- 8408-8418
- ISSN
- 0022-2623 (ISSN-L)
- 1520-4804
- OpenAlex
- W3042595256
- Cited by
- 429
- References
- 70
- FWCI
- 18.82
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.